• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Valeant Pharmaceuticals International

Valeant Pharmaceuticals International

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. UPDATE: Salesforce.com shares rise after earnings, outlook

    UPDATE: Salesforce.com shares rise after earnings, outlook

  2. Valeant close to $1 billion deal for maker of women's libido drug

    Valeant close to $1 billion deal for maker of women's libido drug

  3. UPDATE: MSG, NetApp rise on quarterly results; Salesforce, Gap on deck

    UPDATE: MSG, NetApp rise on quarterly results; Salesforce, Gap on deck

  4. UPDATE: MSG, NetApp rise on quarterly results; Salesforce, Gap on deck

    UPDATE: MSG, NetApp rise on quarterly results; Salesforce, Gap on deck

  5. UPDATE: Media shares drop after Disney downgrade

    UPDATE: Media shares drop after Disney downgrade

  6. UPDATE: Media shares drop after Disney downgrade

    UPDATE: Media shares drop after Disney downgrade

  7. MARKET SNAPSHOT: U.S. Stocks Routed As Media, Consumer, Tech Stocks Tumble

    MARKET SNAPSHOT: U.S. Stocks Routed As Media, Consumer, Tech Stocks Tumble

  8. UPDATE: U.S. stocks routed as media, consumer, tech stocks tumble

    UPDATE: U.S. stocks routed as media, consumer, tech stocks tumble

  9. UPDATE: Salesforce.com shares rise after earnings, outlook

    UPDATE: Salesforce.com shares rise after earnings, outlook

  10. Valeant Confirms Deal for Women's Libido Drug

    Valeant Confirms Deal for Women's Libido Drug

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.